Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2059]

CBD reduces glioblastoma’s size, supportive environment in experimental model

CBD reduces glioblastoma’s size, supportive environment in experimental model

Novel therapy for recurrent brain tumours

Novel therapy for recurrent brain tumours

Study details chromosome-level changes that allow melanomas to develop drug resistance

Study details chromosome-level changes that allow melanomas to develop drug resistance

Analysis tool leads to more-accurate evaluation of new brain tumour treatments and individual estimates of survival

Analysis tool leads to more-accurate evaluation of new brain tumour treatments and individual estimates of survival

Research breakthrough could see HIV drugs used to treat low-grade brain tumours

Research breakthrough could see HIV drugs used to treat low-grade brain tumours

Genetic changes in neuroblastoma leading to tumour evolution

Genetic changes in neuroblastoma leading to tumour evolution

SABCS 2021: Subgroup analysis of trastuzumab deruxtecan shows ‘encouraging’ results in controlling stable brain metastases in HER2-positive metastatic breast cancer

SABCS 2021: Subgroup analysis of trastuzumab deruxtecan shows ‘encouraging’ results in controlling stable brain...

Chemoimmunotherapy dramatically improved survival of high-risk neuroblastoma patients

Chemoimmunotherapy dramatically improved survival of high-risk neuroblastoma patients

Which glioblastoma patients will respond to immunotherapy?

Which glioblastoma patients will respond to immunotherapy?

FDA approves “glowing tumour” imaging drug to better identify ovarian cancer cells

FDA approves “glowing tumour” imaging drug to better identify ovarian cancer cells

More from ecancer